The drug developed by Boston-based Vertex Pharmaceuticals blocks sodium channels in the peripheral nervous system, preventing pain signals from reaching the brain.The approval marks the first new ...

U.S. stocks fall on Friday after the White House says Canada, Mexico and China tariffs will start Saturday. Still, major indexes finish January ahead.

Vertex Pharmaceuticals (VRTX) closed up more than +5% after receiving FDA approval for its non-opioid analgesic Journavx to treat moderate-to-severe acute pain in adults. AbbVie (ABBV) closed up by ...

An effort two decades in the making, Vertex Pharmaceuticals Inc.’s suzetrigine gained U.S. FDA approval as the first drug targeting the NaV1.8 pain signal. Branded Journavx, the oral small molecule is ...